Decitabine combined with minimally myelosuppressive therapy for induction of remission in pediatric high-risk acute myeloid leukemia with chromosome 5q deletion: a report of three cases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Decitabine combined with minimally myelosuppressive therapy for induction of remission in pediatric high-risk acute myeloid leukemia with chromosome 5q deletion: a report of three cases

Published:2022-02-18 Issue:1 Volume:116 Page:146-151
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Cheng Shengqin,Xiao Peifang,Wang Juxiang,Li Zhiheng,Gao Li,Zheng Jiajia,Hu Yixin,Ding Xin,Ling Jing,Lu Qin,Pan Jian,Li Bohan,Lu Jun,Wang Yi,Ribeiro Raul C.,Hu Shaoyan

Funder

jiangsu project

suzhou project

national clinical research center for hematological disorders

nci grant

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-022-03309-9.pdf

Reference16 articles.

1. Venugopal S, Mascarenhas J, Steensma DP. Loss of 5q in myeloid malignancies-A gain in understanding of biological and clinical consequences. Blood Rev. 2021;46:100735.

2. Schwartz JR, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017;8(1):1557.

3. Tsurusawa M, Manabe A, Hayashi Y, Akiyama Y, Kigasawa H, Inada H, et al. Therapy-related myelodysplastic syndrome in childhood: a retrospective study of 36 patients in Japan. Leuk Res. 2005;29(6):625–32.

4. Johnston DL, Alonzo TA, Gerbing RB, Hirsch B, Heerema NA, Ravindranath Y, et al. Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the children’s oncology group. Pediatr Blood Cancer. 2013;60(12):2073–8.

5. Manola KN. Cytogenetics of pediatric acute myeloid leukemia. Eur J Haematol. 2009;83(5):391–405.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies;Biomolecules;2022-12-28

2. Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia;Molecules;2022-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3